ARCHIVES

Cancer society, In Major Restructure, Forms New Executive Committee, Bylaws

This article is from The Cancer Letter archive.

Vol. 18 No. 45 | November 20, 1992

Download PDF Visit The Full Archive

Related Articles

ASCO Recommends Aromatase Inhibitors As Adjuvant For Some Breast Cancer

July 30, 2010

PhRMA Offers Assistance For Part D “Doughnut Hole”

June 26, 2009

M.D. Anderson Sells Itself As Research Base For CCOPs

August 8, 1986

In Brief: Rosenthal Names ACS President; Brown, Lynch, Mintz Win ACS Medals of Honor

November 14, 1997

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

January 29, 2010

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983